| Not Yet Recruiting | Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity Hypertension With Overweight or Obesity | Phase 3 | 2026-05-01 |
| Recruiting | A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants Cardiomyopathy | Phase 1 | 2026-04-14 |
| Not Yet Recruiting | A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism Primary Aldosteronism | Phase 2 | 2026-04-01 |
| Recruiting | A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Pa Advanced Unresectable or Metastatic Breast Cancer of Adults | Phase 1 / Phase 2 | 2026-03-27 |
| Recruiting | A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain Diabetic Peripheral Neuropathic Pain | Phase 1 | 2026-03-24 |
| Recruiting | A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Ki Chronic Kidney Disease | Phase 3 | 2026-03-13 |
| Recruiting | A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis Moderate Pain in Knee Osteoarthritis, Severe Pain in Knee Osteoarthritis | Phase 1 | 2026-03-10 |
| Recruiting | A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Meta Locally Advanced or Metastatic Breast Cancer | Phase 3 | 2026-03-04 |
| Recruiting | A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With High-Risk Early Breast C Breast Cancer | Phase 3 | 2026-03-04 |
| Not Yet Recruiting | A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function Hyperlipidemias | Phase 1 | 2026-01-01 |
| Not Yet Recruiting | A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects. Breast Cancer | Phase 1 | 2026-01-01 |
| Completed | A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects Cardiomyopathy | Phase 1 | 2025-12-11 |
| Completed | A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazol Obesity, Overweight | Phase 1 | 2025-12-08 |
| Not Yet Recruiting | A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction Heart Failure With Preserved Ejection Fraction | Phase 2 | 2025-12-01 |
| Completed | A Trial of Itraconazole Effect on HRS-8080 Pharmacokinetics in Healthy Participants Breast Cancer | Phase 1 | 2025-11-26 |
| Recruiting | A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia Hyperlipidemia | Phase 2 | 2025-11-25 |
| Recruiting | A Phase Ⅱ/Ⅲ Study of HRS-2129 for Postsurgical Pain Management in Abdominal Surgery Postoperative Analgesia | Phase 2 / Phase 3 | 2025-10-24 |
| Recruiting | A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patient Adult Patients With Moderately to Severely Active Ulcerative Colitis | Phase 2 | 2025-10-17 |
| Completed | A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects Hyperlipidemia | Phase 1 | 2025-10-09 |
| Recruiting | A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy Obstructive Hypertrophic Cardiomyopathy | Phase 3 | 2025-08-11 |
| Recruiting | A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Ca Locally Advanced Breast Cancer, Metastatic Breast Cancer | Phase 3 | 2025-07-23 |
| Recruiting | A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors Solid Tumors | Phase 2 | 2025-07-09 |
| Recruiting | A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy Hypertrophic Cardiomyopathy | Phase 2 | 2025-07-04 |
| Completed | Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Hepatic Impairment and Normal Hepati Diabetes Mellitus | Phase 1 | 2025-06-05 |
| Recruiting | A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant Advanced Malignant Tumour | Phase 2 | 2025-04-28 |
| Recruiting | A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors Advanced/Metastatic Solid Tumors | Phase 1 / Phase 2 | 2025-04-24 |
| Recruiting | Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Eje Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity | Phase 2 | 2025-04-10 |
| Active Not Recruiting | A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity Overweight, Obesity | Phase 3 | 2025-04-09 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1301 in Healthy Subje Hyperlipidemia | Phase 1 | 2025-03-18 |
| Recruiting | Clinical Study of HRS-2129 for Postoperative Analgesia in Orthopaedics Postoperative Pain in Orthopaedics | Phase 1 / Phase 2 | 2025-03-11 |
| Completed | A Clinical Study of Mass Balance of [14C]HRS-7535 Type 2 Diabetes Mellitus, Weight Loss | Phase 1 | 2025-02-27 |
| Recruiting | A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy Non-obstructive Hypertrophic Cardiomyopathy | Phase 2 | 2025-02-25 |
| Completed | A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events Treatment of Lipoprotein Disorder | Phase 2 | 2025-02-18 |
| Completed | Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Funct Hypertrophic Cardiomyopathy | Phase 1 | 2025-02-11 |
| Recruiting | A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Br Advanced Unresectable or Metastatic Breast Cancer | Phase 1 / Phase 2 | 2025-01-21 |
| Recruiting | A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patient Advanced Solid Tumors | Phase 1 | 2025-01-21 |
| Completed | A Multiple Ascending Dose Trial of HRS-2129 in Healthy Subjects Pain | Phase 1 | 2024-12-30 |
| Recruiting | Multicenter Phase I Study of HRS-6208 in Patients With Solid Tumors Solid Tumors | Phase 1 | 2024-12-17 |
| Not Yet Recruiting | Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human Diabetes | Phase 1 | 2024-12-01 |
| Completed | Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects Chronic Weight Management | Phase 2 | 2024-11-20 |
| Active Not Recruiting | A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects Overweight or Obesity | Phase 1 / Phase 2 | 2024-10-30 |
| Completed | A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects Pain | Phase 1 | 2024-10-17 |
| Not Yet Recruiting | A Phase 1, Randomized, Crossover Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Breast Cancer | Phase 1 | 2024-10-10 |
| Recruiting | A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Co Type 2 Diabetes | Phase 3 | 2024-09-27 |
| Active Not Recruiting | A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controll Type 2 Diabetes | Phase 3 | 2024-09-25 |
| Active Not Recruiting | A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy Obstructive Hypertrophic Cardiomyopathy | Phase 2 | 2024-08-11 |
| Not Yet Recruiting | Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets i Type 2 Diabetes Mellitus | Phase 1 | 2024-07-01 |
| Completed | Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes Diabetic Kidney Disease, Type 2 Diabetes | Phase 2 | 2024-06-21 |
| Completed | Safety and Tolerance of Increased Doses of HRS-5346 Tablets in Healthy Subjects Lipoprotein Disorder Disease | Phase 1 | 2024-06-13 |
| Recruiting | A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour Advanced Malignant Tumour | Phase 1 | 2024-06-06 |
| Completed | Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i. Type 2 Diabetes | Phase 2 | 2024-05-17 |
| Not Yet Recruiting | Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects Type 2 Diabetes Mellitus | Phase 1 | 2024-05-15 |
| Completed | Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects Obstructive Hypertrophic Cardiomyopathy | Phase 1 | 2024-04-26 |
| Unknown | Drug-drug Interaction Study of HRS-1780 Tablets in Healthy Subjects Chronic Kidney Disease(CKD) | Phase 1 | 2024-04-01 |
| Completed | Efficacy and Safety of HRS-1780 Tablets and Henagliflozin Proline Tablets in Patients With Chronic Kidney Dise Chronic Kidney Disease | Phase 2 | 2024-03-02 |
| Completed | Efficacy and Safety of HRS-7535 Tablets in Obese Subjects . Overweight and Obesity | Phase 2 | 2024-02-23 |
| Recruiting | Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Br Breast Cancer | Phase 1 / Phase 2 | 2024-02-20 |
| Completed | Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subje Type 2 Diabetes | Phase 1 | 2023-12-21 |
| Recruiting | Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable o Unresectable or Metastatic Breast Cancer | Phase 1 / Phase 2 | 2023-12-20 |
| Unknown | A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safet Inflammatory Bowel Disease | Phase 1 | 2023-12-01 |
| Unknown | Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function Chronic Kidney Disease | Phase 1 | 2023-09-01 |
| Completed | A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy Obstructive Hypertrophic Cardiomyopathy | Phase 1 | 2023-06-05 |
| Unknown | Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors Advanced Malignant Tumor | Phase 1 | 2023-05-26 |
| Unknown | A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus Type 2 Diabetes | Phase 2 | 2023-02-28 |
| Recruiting | A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer Breast Cancer | Phase 1 | 2023-02-07 |
| Unknown | Safety and Tolerance of Increased Doses of HRS-1780 Tablets in Healthy Subjects Chronic Kidney Disease | Phase 1 | 2023-02-02 |
| Completed | A HR20031 FE Study on Healthy Subjects Type 2 Diabetes | Phase 1 | 2023-01-31 |
| Completed | A HR20031 BE Study on Healthy Subjects Type 2 Diabetes | Phase 1 | 2023-01-31 |
| Completed | Study of the Bioequivalence and Food Effects of HRX0701 Tablets in Healthy Subjects Type 2 Diabetes Mellitus | Phase 1 | 2022-07-05 |
| Unknown | A Phase I Single- and Multiple- Ascending Dose and Food Effect Study to Evaluate the Safety, Tolerability, Pha Healthy Subjects | Phase 1 | 2022-05-01 |
| Unknown | A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults Metastatic or Local Advanced Breast Cancer of Patients | Phase 1 | 2022-02-17 |
| Unknown | A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the Type II Diabetes | Phase 1 | 2021-11-09 |
| Unknown | A Study to Assess the Effect of Food on HR20033 and Pharmacokinetic After Multiple Dose in Healthy Volunteers Type II Diabetes | Phase 1 | 2021-10-13 |